Posted by Michael Wonder on 22 Oct 2018
What pharma giant Johnson & Johnson's CEO has to say about the drug price debate
18 October 2018 - “We’ve never seen time where the level of innovation has been richer and more exciting than what we’re seeing today,” Gorsky told Erika. “The challenge is, how do we pay for that? How do we price it in a responsible manner?”
“I think educated consumers and patients are in everyone’s best interest,” he said. “Transparency is also a benefit.”
Now, here comes the caveat… “But we need to be aware of not making things even more confusing. What price do we talk about? List price? The net price? The price to the government?”
